Results 191 to 193 of about 7,679 (193)

Biologics (mepolizumab and omalizumab) induced remission in severe asthma patients

Allergy: European Journal of Allergy and Clinical Immunology
John Upham, Mark Hew, Sandra Hodge
exaly  

Mepolizumab depletes inflammatory but preserves homeostatic eosinophils in severe asthma

Allergy: European Journal of Allergy and Clinical Immunology
Michael Fricker
exaly  

Pharmacokinetics and pharmacodynamics of mepolizumab, an anti–interleukin 5 monoclonal antibody, in healthy Japanese male subjects

Clinical Pharmacology in Drug Development, 2016
exaly